X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
female (15) 15
hematology, oncology and palliative medicine (15) 15
aged (14) 14
male (14) 14
middle aged (13) 13
adult (11) 11
oncology (11) 11
radiotherapy (8) 8
aged, 80 and over (7) 7
cancer (7) 7
treatment outcome (7) 7
breast cancer (6) 6
therapy (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
combined modality therapy (5) 5
adolescent (4) 4
care and treatment (4) 4
follow-up studies (4) 4
retrospective studies (4) 4
child (3) 3
combination chemotherapy (3) 3
disease-free survival (3) 3
hematology (3) 3
index medicus (3) 3
lymphoma, non-hodgkin - drug therapy (3) 3
management (3) 3
neoplasm staging (3) 3
radiotherapy dosage (3) 3
survival rate (3) 3
testicular neoplasms - radiotherapy (3) 3
analysis (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
breast neoplasms - radiotherapy (2) 2
chemotherapy (2) 2
cyclophosphamide - administration & dosage (2) 2
disease progression (2) 2
doxorubicin - administration & dosage (2) 2
drug administration schedule (2) 2
endoscopy (2) 2
etoposide - administration & dosage (2) 2
etoposide - adverse effects (2) 2
follow-up (2) 2
gallium radioisotopes (2) 2
gastric lymphoma (2) 2
hodgkin disease - mortality (2) 2
hodgkin disease - therapy (2) 2
infant (2) 2
k dm oncology (2) 2
lymphoma (2) 2
lymphoma, non-hodgkin - mortality (2) 2
lymphoma, non-hodgkin - therapy (2) 2
mycosis fungoides (2) 2
mycosis fungoides - radiotherapy (2) 2
non-hodgkin's lymphoma (2) 2
non-hodgkin's lymphomas (2) 2
ovarian cancer (2) 2
prednisone - administration & dosage (2) 2
prognosis (2) 2
prospective studies (2) 2
radiology, nuclear medicine & medical imaging (2) 2
recurrence (2) 2
regimen (2) 2
remission induction (2) 2
seminoma - radiotherapy (2) 2
skin neoplasms - radiotherapy (2) 2
stage i (2) 2
surgery (2) 2
survival (2) 2
vincristine - administration & dosage (2) 2
21-kda protein (1) 1
abdomen (1) 1
abridged index medicus (1) 1
acute skin toxicity (1) 1
adenocarcinoma - etiology (1) 1
adp (1) 1
age (1) 1
age factors (1) 1
agranulocytosis - chemically induced (1) 1
alanine (1) 1
androstadienes - administration & dosage (1) 1
androstadienes - adverse effects (1) 1
anemia (1) 1
anticancer properties (1) 1
anticoagulants (1) 1
antigens, neoplasm (1) 1
antitumor activity (1) 1
aromatase inhibitors - administration & dosage (1) 1
aromatase inhibitors - adverse effects (1) 1
arthralgia syndrome (1) 1
aspartate aminotransferase (1) 1
aspirin (1) 1
atac trial (1) 1
auswertung (1) 1
beam radiation-therapy (1) 1
benign (1) 1
betrug (1) 1
bevacizumab (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Coleman, Robert L and Coleman, R L and Oza, Amit M and Oza, A M and Lorusso, D and Lorusso, Domenica and Aghajanian, C and Aghajanian, Carol and Oaknin, A and Oaknin, Ana and Dean, A and Dean, Andrew and Colombo, N and Colombo, Nicoletta and Weberpals, Johanne I and Weberpals, J I and Clamp, Andrew and Clamp, A and Scambia, Giovanni and Scambia, G and Leary, A and Leary, Alexandra and Holloway, Robert W and Holloway, R W and Gancedo, M Amenedo and Gancedo, Margarita Amenedo and Fong, Peter C and Fong, P C and Goh, Jeffrey C and Goh, J C and O'Malley, David M and O'Malley, D M and Armstrong, Deborah K and Armstrong, D K and Garcia-Donas, Jesus and Garcia-Donas, J and Swisher, E M and Swisher, Elizabeth M and Floquet, A and Floquet, Anne and Konecny, Gottfried E and Konecny, G E and McNeish, I A and McNeish, Iain A and Scott, C L and Scott, Clare L and Cameron, Terri and Maloney, Lara and Isaacson, Jeff and Goble, Sandra and Grace, Caroline and Harding, Thomas C and Raponi, Mitch and Sun, James and Lin, Kevin K and Giordano, Heidi and Ledermann, J A and Ledermann, Jonathan A and Buck, M and Friedlander, M L and Harnett, P and Kichenadasse, G and Denys, H and Dirix, L and Vergote, I and Elit, L and Ghatage, P and Plante, M and Provencher, D and Welch, S and Gladieff, L and Joly, F and Lortholary, A and Lotz, J and Medioni, J and Tredan, O and You, B and El-Balat, A and Hänle, C and Krabisch, P and Neunhöffer, T and Pölcher, M and Wimberger, P and Amit, A and Kovel, S and Leviov, M and Safra, T and Shapira-Frommer, R and Stemmer, S and Bologna, A and Pignata, S and Sabbatini, R F and Tamberi, S and Zamagni, C and O'Donnell, A and Herraez, A Casado and Guerra, E M and Palacio, I and Romero, I and Sanchez, A and ... and ARIEL3 Investigators and ARIEL3 investigators
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10106, pp. 1949 - 1961
Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a mutation or high percentage of... 
MEDICINE, GENERAL & INTERNAL | MULTICENTER | SOLID TUMORS | BEVACIZUMAB | OPEN-LABEL | CANCER | HETEROZYGOSITY | EPITHELIAL OVARIAN | CHEMOTHERAPY | Double-Blind Method | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Survival Rate | Treatment Outcome | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Indoles - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Maintenance Chemotherapy - methods | Internationality | Ovarian Neoplasms - therapy | Female | Aged | Molecular Targeted Therapy - methods | Clinical trials | Care and treatment | Carcinoma | Drug therapy | Ovarian cancer | Cancer | Analysis | Chemotherapy | Ovarian carcinoma | Platinum | Biomarkers | Mutation | Cancer therapies | Tumors | Homologous recombination | Central nervous system | Poly(ADP-ribose) | Homology | Genomes | Fallopian tube | ADP | Anticancer properties | Metastases | Homologous recombination repair | Randomization | Pain | Motivation | Ribose | Hemoglobin | Alanine | Anemia | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Survival | Heterozygosity | Abdomen | Polymerase | Inhibitors | Point mutation | Loss of heterozygosity | Antitumor activity | Aspartate aminotransferase | Peritoneum
Journal Article
Journal Article
The Breast, ISSN 0960-9776, 03/2017, Volume 32, pp. S76 - S76
Journal Article
Breast, The, ISSN 0960-9776, 2017, Volume 32, pp. S76 - S76
Journal Article
The Breast, ISSN 0960-9776, 03/2017, Volume 32, pp. S99 - S99
Journal Article
The Breast, ISSN 0960-9776, 03/2017, Volume 32, p. S99
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2011, Volume 29, Issue 15_suppl, pp. e11092 - e11092
Journal Article
GYNECOLOGIC ONCOLOGY, ISSN 0090-8258, 05/2014, Volume 133, Issue 2, pp. 304 - 308
Objectives. Studies suggest that statins and low dose aspirin reduce risk of VTEs in the general population. We aimed to study the effect of these drugs on the... 
Venous thromboembolic events | MORTALITY | SURVIVAL | Aspirin | COA REDUCTASE INHIBITORS | Deep vein thrombosis | DEEP-VEIN THROMBOSIS | Ovarian cancer | OBSTETRICS & GYNECOLOGY | Pulmonary embolism | REDUCED INCIDENCE | THERAPY | VENOUS THROMBOEMBOLISM | ONCOLOGY | Statins | ROSUVASTATIN
Journal Article
Breast, The, ISSN 0960-9776, 2011, Volume 20, pp. S63 - S63
Journal Article
Breast, The, ISSN 0960-9776, 2011, Volume 20, pp. S63 - S63
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2007, Volume 64, pp. S33 - S33
Journal Article
Breast, The, ISSN 0960-9776, 2009, Volume 18, pp. S32 - S33
Journal Article
Journal of Geriatric Oncology, ISSN 1879-4068, 2013, Volume 4, pp. S33 - S33
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.